To accommodate patients remotely during the COVID-19 pandemic, practices may have expanded personnel access to protected health information and relied on devices that might be vulnerable to cyber attacks.
Researchers from the New York State Department of Health found that current COVID-19 convalescent plasma guidelines may be allowing for sera with low neutralizing capacity to be administered.
The randomized, placebo-controlled, observer-blind study is evaluating the safety, tolerability, and immunogenicity of BNT162b2 in approximately 4000 healthy pregnant women aged 18 years and older who are 24 to 34 weeks’ gestation.
Face masks will be mandatory at transportation hubs and on planes and all forms of public transportation under a US Centers for Disease Control and Prevention order.
For light sedation of mechanically ventilated adults with sepsis, outcomes do not differ significantly for those receiving dexmedetomidine or propofol.
Study authors assessed whether convalescent plasma with high SARS-CoV-2 antibody titers would prevent progression to severe disease in older patients with COVID-19 if administered within 72 hours after the onset of mild symptoms.
Study authors compared oral moxifloxacin with combined intravenous ertapenem followed by oral levofloxacin in the managed of uncomplicated acute appendicitis.
Study authors described trends in US outpatient antibiotic prescriptions from January through May, 2020, and compared these trends with previous years.
The European Commission on Medical Mycology and International Society for Human and Animal Mycology released clinical guidance and research criteria for managing invasive pulmonary aspergillosis among patients with SARS-CoV-2.
The study authors aimed to estimate the prevalence and critical determinants ofpsychological distress among gastroenterologists during the COVID-19 pandemic.
Investigators assessed whether a daily service of infectious disease consultation was more effective than weekly consultation to reduce antibiotic use without worsening clinical outcomes.
This detailed description of an institutional response to the COVID-19 pandemic in NYC highlights approaches that can be applied to help other hospitals plan for surges.
